STING & TLR Targeting Therapies
Associate Professor - Melanoma Medical Oncology - MD Anderson Cancer Center
Chief Scientific Officer - Synlogic
Assistant Professor - Phase, Therapeutics & Melanoma - University of Pittsburgh
Chief Executive Officer - Avidea Technologies
President & CEO - Tallac Therapeutics
CSO, Co-founder, Director & Senior VP - Research & Development - Primmune Therapeutics, Inc.
Director - Mersana Therapeutics
Head of Translational Research & Innovation - Affimed GmbH
Senior Director - Drug Discovery - Vir Biotechnology Inc.
Senior Director & Head of Project Leader Group, Innate Immunity Research Unit - GlaxoSmithKline
Project Leader - F-star Biotechnology Ltd.
Chief Scientific Officer & Executive Vice President - Ryvu Therapeutics
Director - Pharmacology - Codiak Biosciences
Vice President - Research & Cofounder - Actym Therapeutics
M.D. - Innsbruck Medical University
Chief Scientific Officer - STipe Therapeutics
President and CEO - Decoy Biosystems
Senior Scientist - Cancer Immunotherapy Drug Discovery - Mersana Therapeutics
Principal Investigator - Institut Curie
Chief Medical Officer - Seven and Eight Biopharmaceuticals Inc.
Associate Professor - Harvard Medical School
Director - Cancer Research & Scientific - Boehringer Ingelheim
Chief Scientific Officer, Co-founder & Head of Research & Development - Verseau Therapeutics
Chief Computational Scientist - Silicon Therapeutics
Chief Scientific Officer - 4D Pharma PLC
Associate Director, Translational Applications - Nilogen Oncosystems
Senior Vice President - Discovery, Preclinical Models & Services - GenOway
Senior Director - Discovery Research - Myeloid Therapeutics
Associate Director - AstraZeneca
Chief of Research & Development - Silicon Therapeutics
Senior VP Oncology & Translational Medicine, Chief Development Officer ad interim - CureVac
Chief Academic Officer - BILH and BIDMC
Chief Scientific Officer - Trillium Therapeutics Inc
Senior Director - H3 Biomedicine
Chief Medical Officer - Bolt Biotherapeutics
Founder, Chief Scientific Officer & Chief Executive Officer - Checkmate Pharmaceuticals
Professor - UMass Medical School
Vice President of Clinical Development - Istari Oncology Inc.
4D pharma plc
Developing Science, Delivering Therapies
Make better decisions for your translational immune-oncology program with the most clinically-relevant 3D cancer model – 3D-EXplore
Where DNA breaks, our insight begins
Connect with your peers while onsite!